Paul Cumming
Affiliations: | Biological Psychiatry | Ludwig Maximilians University, München, Bayern, Germany |
Area:
Dopamine, ImagingGoogle:
"Paul Cumming"Mean distance: 16.56 (cluster 11)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lu J, Bao W, Li M, et al. (2020) Associations of [F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism. Frontiers in Neuroscience. 14: 604 |
| Han X, Wu P, Alberts I, et al. (2020) Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder. Neuroimage. Clinical. 27: 102294 |
| Sacher C, Blume T, Beyer L, et al. (2020) Asymmetry of fibrillar plaque burden in amyloid mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Weidenauer A, Bauer M, Sauerzopf U, et al. (2020) On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D receptor agonist radioligand study. Translational Psychiatry. 10: 2 |
| Beyer L, Brendel M, Scheiwein F, et al. (2020) Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer's Disease : Jad |
| Huber M, Beyer L, Prix C, et al. (2019) Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society |
| Cumming P, Marton J, Lilius TO, et al. (2019) A Survey of Molecular Imaging of Opioid Receptors. Molecules (Basel, Switzerland). 24 |
| Brendel M, Deussing M, Blume T, et al. (2019) Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau. Alzheimer's Research & Therapy. 11: 67 |
| Kim JH, Choe YS, Cumming P, et al. (2019) Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: an [ F]fallypride PET and fMRI study. Synapse (New York, N.Y.) |
| Gründer G, Cumming P. (2019) The downside of downregulation. Brain : a Journal of Neurology. 142: 1500-1502 |